Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Market Cap	1.42B
Revenue (ttm)	428.63M
Net Income (ttm)	46.56M
Shares Out	103.81M
EPS (ttm)	0.45
PE Ratio	30.35
Forward PE	n/a
Dividend	0.11 (0.81%)
Ex-Dividend Date	Dec 17, 2025

Volume	93,265
Average Volume	231,383
Open	13.70
Previous Close	13.50
Day's Range	13.60 - 13.90
52-Week Range	11.10 - 18.50
Beta	0.21
RSI	52.93
Earnings Date	Jan 29, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 313
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.